Tirzepatide benefits being studied.
Tirzepatide works through two hormone signals involved in the body’s response to food. Its research story is easy to recognise: changes in appetite, food intake and body weight.
- Lower body weight in controlled trials.
- Less hunger and fewer food cravings in a short clinical study.
- Lower food intake and greater fasting fullness in that study.
In a six-week study of 114 adults with overweight or obesity, tirzepatide lowered appetite, hunger, cravings and food intake compared with placebo. Participants did not have diabetes. Published appetite and food-intake study.
A longer trial measured substantial weight reduction.
In the 72-week SURMOUNT-1 trial, the group receiving the highest trial dose had an average weight reduction of 20.9%, compared with 3.1% with placebo. The participants had obesity or overweight and did not have diabetes. Published SURMOUNT-1 trial.
The appetite study and the weight study answer related questions. One examines how eating-related feelings and intake change; the other follows body weight over a longer period. These findings describe the specific clinical study preparations.
Know which product you are enquiring about.
Tirzepatide is an ingredient in approved prescription medicines. A laboratory research material is a separate product with its own specification. FDA product information.
For a catalogue enquiry, use the full name “tirzepatide” and request the current material and pack details. You can also read our retatrutide overview to understand the other name often discussed in metabolic research.
Ask about Tirzepatide.
Email sales@wholesalelabpeptides.com for the current research catalogue, product details and wholesale prices. Tell us the material and your delivery country.
Request catalogue and prices